fda bpc-157 warning not approved for human use FDA's Overreach on Compounded Peptides bpc-157 fda warning news FDA
Description
Stable gastric pentadecapeptide BPC 157 heals established vesicovaginal fistula and counteracts stone formation in rats
The benzyl alcohol preservative maintains the sterility of the solution between uses, making it ideal for research protocols that require repeated access to a single vial over an extended period

Citation: Smart, N., & Venter, D

The treatment may include injections that are given every day for 10 days then tailored as per the patients need and inject regularly every few weeks or months
Ikeda K, Maretich P, Kajimura S
